Beyond-Rule-of-Five Compounds Are Not Different: In Vitro-In Vivo Extrapolation of Female CD-1 Mouse Clearance Based on Merck Healthcare KGaA Compound Set

被引:0
作者
Maurer, Christine K. [1 ]
Fang, Zhizhou [1 ]
Duevel, Heide M. [1 ]
Harlfinger, Stephanie [1 ]
Petersson, Carl [1 ]
机构
[1] Merck Healthcare KGaA, NCE DMPK, Frankfurter Str 250, D-64293 Darmstadt, Germany
关键词
in vitro-in vivo extrapolation; metabolic clearance; microsomes; hepatocytes; fraction unbound in the incubation; PROTACs; (c); beyond-rule-of-five; ADME; DMPK; INTRINSIC CLEARANCE; NONSPECIFIC-BINDING; METABOLIC-CLEARANCE; HALF-LIFE; PREDICTION; DRUGS;
D O I
10.3390/ph18040568
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Background: Extrapolation of intrinsic clearance from in vitro systems such as liver microsomes or hepatocytes is an established approach to predict clearance in preclinical species and in humans. A common discussion in the literature is whether the predictive accuracy of such extrapolations is influenced by the chemotype and whether these methods are also applicable to compounds studied in early drug discovery programs. Compounds in such programs are frequently lipophilic and show low solubility and low free fraction in plasma, which may pose challenges to the extrapolation of clearance different from those of the final clinical candidates. A similar discussion has been raised about compounds residing beyond the traditional small-molecule property space, such as PROTACs (c) and other molecules incompatible with Lipinski's rule-of-five. Methods: To further enlighten the field on these matters, we present a study comparing the predictive accuracy between mouse hepatocytes and microsomes for a set of molecules (N = 211) from the Merck Healthcare drug discovery pipeline. This set was dominated by compounds belonging to class 2 and 4 of the extended clearance classification systems (ECCS). It contained a similar proportion of molecules compliant with the Lipinski rule-of-five (N = 127) and molecules lacking such compliance (N = 84). Results: This study showed no or little differences in predictive accuracy nor bias between the two groups, with an average fold error close to 1, an absolute average fold error of just over 2, and around 50% being within 2-fold and >90% being within 5-fold of the predicted unbound clearance in both in vitro systems. Furthermore, no significant differences in accuracy were observed for compounds with an extremely low free fraction (down to 0.05%) in plasma. Conclusions: The accuracy of in vitro-in vivo extrapolation of female CD-1 mouse clearance was not affected by the physicochemical properties.
引用
收藏
页数:16
相关论文
共 28 条
[1]   Finding a needle in the haystack: ADME and pharmacokinetics/pharmacodynamics characterization and optimization towards orally available bifunctional protein degraders [J].
Apprato, Giulia ;
Caron, Giulia ;
Deshmukh, Gauri ;
Garcia-Jimenez, Diego ;
Haid, Robin Thomas Ulrich ;
Pike, Andy ;
Reichel, Andreas ;
Rynn, Caroline ;
Zhang, Donglu ;
Wittwer, Matthias Beat .
EXPERT OPINION ON DRUG DISCOVERY, 2025, 20 (03) :373-389
[2]   BASIC PRINCIPLES OF PHARMACOKINETICS [J].
BENET, LZ ;
ZIAAMIRHOSSEINI, P .
TOXICOLOGIC PATHOLOGY, 1995, 23 (02) :115-123
[3]   PHYSIOLOGICAL-PARAMETERS IN LABORATORY-ANIMALS AND HUMANS [J].
DAVIES, B ;
MORRIS, T .
PHARMACEUTICAL RESEARCH, 1993, 10 (07) :1093-1095
[4]   Measurement of total liver blood flow in intact anesthetized rats using ultrasound imaging [J].
Gibson, Christopher R. ;
Gleason, Alexa ;
Messina, Eric .
PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (02)
[5]   Generation of a set of simple, interpretable ADMET rules of thumb [J].
Gleeson, M. Paul .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (04) :817-834
[6]   Use of Segregated Hepatocyte Scaling Factors and Cross-Species Relationships to Resolve Clearance Dependence in the Prediction of Human Hepatic Clearance [J].
Hallifax, D. ;
Houston, J. B. .
DRUG METABOLISM AND DISPOSITION, 2019, 47 (03) :320-327
[7]   Hepatocellular binding of drugs: Correction for unbound fraction in hepatocyte incubations using microsomal binding or drug lipophilicity data [J].
Kilford, Peter J. ;
Gertz, Michael ;
Houston, J. Brian ;
Galetin, Aleksandra .
DRUG METABOLISM AND DISPOSITION, 2008, 36 (07) :1194-1197
[8]   Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings [J].
Lipinski, CA ;
Lombardo, F ;
Dominy, BW ;
Feeney, PJ .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 23 (1-3) :3-25
[9]   Metabolism of human cytochrome P450 marker substrates in mouse:: a strain and gender comparison [J].
Löfgren, S ;
Hagbjörk, AL ;
Ekman, S ;
Fransson-Steen, R ;
Terelius, Y .
XENOBIOTICA, 2004, 34 (09) :811-834
[10]   Drug Design and Success of Prospective Mouse In Vitro-In Vivo Extrapolation (IVIVE) for Predictions of Plasma Clearance (CLp) from Hepatocyte Intrinsic Clearance (CLint) [J].
Manevski, Nenad ;
Umehara, Kenichi ;
Parrott, Neil .
MOLECULAR PHARMACEUTICS, 2023, 20 (07) :3438-3459